nodes	percent_of_prediction	percent_of_DWPC	metapath
Fomepizole—CAT—psoriasis	0.721	1	CbGaD
Fomepizole—CYP2A6—Methoxsalen—psoriasis	0.0777	0.51	CbGbCtD
Fomepizole—CYP2A6—Prednisolone—psoriasis	0.0378	0.248	CbGbCtD
Fomepizole—CYP2A6—Dexamethasone—psoriasis	0.0223	0.146	CbGbCtD
Fomepizole—CYP2E1—Dexamethasone—psoriasis	0.0147	0.0964	CbGbCtD
Fomepizole—ADH1C—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00311	0.0774	CbGpPWpGaD
Fomepizole—ADH1B—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00311	0.0774	CbGpPWpGaD
Fomepizole—ADH1A—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00257	0.0642	CbGpPWpGaD
Fomepizole—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.00239	0.0596	CbGpPWpGaD
Fomepizole—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00189	0.0471	CbGpPWpGaD
Fomepizole—ADH1C—Biological oxidations—CYP2S1—psoriasis	0.00165	0.0411	CbGpPWpGaD
Fomepizole—ADH1B—Biological oxidations—CYP2S1—psoriasis	0.00165	0.0411	CbGpPWpGaD
Fomepizole—CAT—endothelium—psoriasis	0.00159	0.395	CbGeAlD
Fomepizole—CYP2A6—Xenobiotics—CYP2S1—psoriasis	0.00148	0.037	CbGpPWpGaD
Fomepizole—ADH1A—Biological oxidations—CYP2S1—psoriasis	0.00137	0.0341	CbGpPWpGaD
Fomepizole—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00117	0.0292	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—IL4—psoriasis	0.000882	0.022	CbGpPWpGaD
Fomepizole—CAT—Oxidative Stress—NFKB1—psoriasis	0.000834	0.0208	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—CRP—psoriasis	0.000763	0.019	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—ICAM1—psoriasis	0.000701	0.0175	CbGpPWpGaD
Fomepizole—CAT—skin of body—psoriasis	0.000679	0.169	CbGeAlD
Fomepizole—ADH1C—tendon—psoriasis	0.000659	0.164	CbGeAlD
Fomepizole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000616	0.0154	CbGpPWpGaD
Fomepizole—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000608	0.0152	CbGpPWpGaD
Fomepizole—CAT—Selenium Micronutrient Network—CRP—psoriasis	0.000606	0.0151	CbGpPWpGaD
Fomepizole—CAT—Selenium Micronutrient Network—ICAM1—psoriasis	0.000557	0.0139	CbGpPWpGaD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—TNF—psoriasis	0.000537	0.0134	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—IFNG—psoriasis	0.000533	0.0133	CbGpPWpGaD
Fomepizole—CAT—tendon—psoriasis	0.000517	0.129	CbGeAlD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000499	0.0124	CbGpPWpGaD
Fomepizole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000487	0.0121	CbGpPWpGaD
Fomepizole—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00048	0.012	CbGpPWpGaD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—TP53—psoriasis	0.000473	0.0118	CbGpPWpGaD
Fomepizole—ADH1B—tendon—psoriasis	0.000466	0.116	CbGeAlD
Fomepizole—CAT—Folate Metabolism—NFKB1—psoriasis	0.000444	0.0111	CbGpPWpGaD
Fomepizole—CAT—Selenium Micronutrient Network—IFNG—psoriasis	0.000424	0.0106	CbGpPWpGaD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000395	0.00984	CbGpPWpGaD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.000386	0.00961	CbGpPWpGaD
Fomepizole—CAT—Selenium Micronutrient Network—NFKB1—psoriasis	0.000353	0.00879	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—TNF—psoriasis	0.000345	0.00861	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—NDUFA5—psoriasis	0.000332	0.00827	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—NDUFA5—psoriasis	0.000332	0.00827	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—JUN—psoriasis	0.000309	0.00769	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—TP53—psoriasis	0.000304	0.00759	CbGpPWpGaD
Fomepizole—CAT—Metabolism—NDUFA5—psoriasis	0.000299	0.00745	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—NFKB1—psoriasis	0.000297	0.00741	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CYP2S1—psoriasis	0.000282	0.00704	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CYP2S1—psoriasis	0.000282	0.00704	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—IL6—psoriasis	0.000279	0.00694	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—NDUFA5—psoriasis	0.000275	0.00686	CbGpPWpGaD
Fomepizole—CAT—Selenium Micronutrient Network—TNF—psoriasis	0.000274	0.00684	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000265	0.00661	CbGpPWpGaD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000256	0.00637	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CYP2S1—psoriasis	0.000254	0.00633	CbGpPWpGaD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000246	0.00613	CbGpPWpGaD
Fomepizole—Headache—Methoxsalen—psoriasis	0.000236	0.00288	CcSEcCtD
Fomepizole—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000235	0.00287	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CYP2S1—psoriasis	0.000234	0.00583	CbGpPWpGaD
Fomepizole—Back pain—Mycophenolic acid—psoriasis	0.000232	0.00284	CcSEcCtD
Fomepizole—Diarrhoea—Calcitriol—psoriasis	0.000229	0.0028	CcSEcCtD
Fomepizole—Vision blurred—Mycophenolic acid—psoriasis	0.000226	0.00276	CcSEcCtD
Fomepizole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000224	0.00557	CbGpPWpGaD
Fomepizole—Nausea—Methoxsalen—psoriasis	0.000223	0.00273	CcSEcCtD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000223	0.00557	CbGpPWpGaD
Fomepizole—Anaemia—Mycophenolic acid—psoriasis	0.000222	0.00271	CcSEcCtD
Fomepizole—Bradycardia—Mycophenolate mofetil—psoriasis	0.000222	0.00271	CcSEcCtD
Fomepizole—Pharyngitis—Cyclosporine—psoriasis	0.000222	0.0027	CcSEcCtD
Fomepizole—CAT—Selenium Micronutrient Network—IL6—psoriasis	0.000221	0.00552	CbGpPWpGaD
Fomepizole—Agitation—Mycophenolic acid—psoriasis	0.000221	0.00269	CcSEcCtD
Fomepizole—Pharyngitis—Mycophenolate mofetil—psoriasis	0.000216	0.00264	CcSEcCtD
Fomepizole—Vertigo—Mycophenolic acid—psoriasis	0.000216	0.00263	CcSEcCtD
Fomepizole—Visual impairment—Cyclosporine—psoriasis	0.000215	0.00263	CcSEcCtD
Fomepizole—Vomiting—Calcitriol—psoriasis	0.000213	0.0026	CcSEcCtD
Fomepizole—Rash—Calcitriol—psoriasis	0.000211	0.00258	CcSEcCtD
Fomepizole—Dermatitis—Calcitriol—psoriasis	0.000211	0.00258	CcSEcCtD
Fomepizole—Headache—Calcitriol—psoriasis	0.00021	0.00256	CcSEcCtD
Fomepizole—Visual impairment—Mycophenolate mofetil—psoriasis	0.00021	0.00256	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.00021	0.00522	CbGpPWpGaD
Fomepizole—Convulsion—Mycophenolic acid—psoriasis	0.000208	0.00254	CcSEcCtD
Fomepizole—Somnolence—Hydroxyurea—psoriasis	0.000208	0.00254	CcSEcCtD
Fomepizole—Flushing—Cyclosporine—psoriasis	0.000207	0.00253	CcSEcCtD
Fomepizole—Bradycardia—Prednisolone—psoriasis	0.000207	0.00252	CcSEcCtD
Fomepizole—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000207	0.00515	CbGpPWpGaD
Fomepizole—Dyspepsia—Hydroxyurea—psoriasis	0.000206	0.00252	CcSEcCtD
Fomepizole—Diarrhoea—Acitretin—psoriasis	0.000204	0.00249	CcSEcCtD
Fomepizole—Anxiety—Mycophenolic acid—psoriasis	0.000204	0.00249	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—TP53—psoriasis	0.000204	0.00508	CbGpPWpGaD
Fomepizole—Decreased appetite—Hydroxyurea—psoriasis	0.000204	0.00248	CcSEcCtD
Fomepizole—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000203	0.00248	CcSEcCtD
Fomepizole—Bradycardia—Hydrocortisone—psoriasis	0.000202	0.00247	CcSEcCtD
Fomepizole—Pain—Hydroxyurea—psoriasis	0.0002	0.00244	CcSEcCtD
Fomepizole—Nausea—Calcitriol—psoriasis	0.000199	0.00243	CcSEcCtD
Fomepizole—Dizziness—Acitretin—psoriasis	0.000197	0.00241	CcSEcCtD
Fomepizole—Dizziness—Fluocinolone Acetonide—psoriasis	0.000197	0.0024	CcSEcCtD
Fomepizole—Visual impairment—Prednisolone—psoriasis	0.000196	0.00239	CcSEcCtD
Fomepizole—Shock—Mycophenolic acid—psoriasis	0.000193	0.00235	CcSEcCtD
Fomepizole—Tachycardia—Mycophenolic acid—psoriasis	0.000191	0.00234	CcSEcCtD
Fomepizole—Dysgeusia—Cyclosporine—psoriasis	0.00019	0.00232	CcSEcCtD
Fomepizole—Bradycardia—Triamcinolone—psoriasis	0.00019	0.00232	CcSEcCtD
Fomepizole—Vomiting—Acitretin—psoriasis	0.00019	0.00231	CcSEcCtD
Fomepizole—Vomiting—Fluocinolone Acetonide—psoriasis	0.000189	0.00231	CcSEcCtD
Fomepizole—Visual disturbance—Methotrexate—psoriasis	0.000188	0.0023	CcSEcCtD
Fomepizole—Rash—Acitretin—psoriasis	0.000188	0.00229	CcSEcCtD
Fomepizole—Dermatitis—Acitretin—psoriasis	0.000188	0.00229	CcSEcCtD
Fomepizole—Rash—Fluocinolone Acetonide—psoriasis	0.000187	0.00229	CcSEcCtD
Fomepizole—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000187	0.00229	CcSEcCtD
Fomepizole—Headache—Acitretin—psoriasis	0.000187	0.00228	CcSEcCtD
Fomepizole—Headache—Fluocinolone Acetonide—psoriasis	0.000186	0.00227	CcSEcCtD
Fomepizole—Dysgeusia—Mycophenolate mofetil—psoriasis	0.000186	0.00227	CcSEcCtD
Fomepizole—Pharyngitis—Triamcinolone—psoriasis	0.000185	0.00226	CcSEcCtD
Fomepizole—Body temperature increased—Hydroxyurea—psoriasis	0.000185	0.00226	CcSEcCtD
Fomepizole—Back pain—Mycophenolate mofetil—psoriasis	0.000183	0.00224	CcSEcCtD
Fomepizole—Hypotension—Mycophenolic acid—psoriasis	0.000183	0.00224	CcSEcCtD
Fomepizole—Vision blurred—Cyclosporine—psoriasis	0.000183	0.00224	CcSEcCtD
Fomepizole—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000181	0.00451	CbGpPWpGaD
Fomepizole—Anaemia—Cyclosporine—psoriasis	0.00018	0.00219	CcSEcCtD
Fomepizole—Agitation—Cyclosporine—psoriasis	0.000179	0.00218	CcSEcCtD
Fomepizole—Nausea—Acitretin—psoriasis	0.000177	0.00216	CcSEcCtD
Fomepizole—Nausea—Fluocinolone Acetonide—psoriasis	0.000177	0.00216	CcSEcCtD
Fomepizole—Anaemia—Mycophenolate mofetil—psoriasis	0.000175	0.00214	CcSEcCtD
Fomepizole—Vertigo—Cyclosporine—psoriasis	0.000175	0.00213	CcSEcCtD
Fomepizole—Somnolence—Mycophenolic acid—psoriasis	0.000174	0.00213	CcSEcCtD
Fomepizole—Agitation—Mycophenolate mofetil—psoriasis	0.000174	0.00213	CcSEcCtD
Fomepizole—Dyspepsia—Mycophenolic acid—psoriasis	0.000173	0.00211	CcSEcCtD
Fomepizole—Bradycardia—Betamethasone—psoriasis	0.000173	0.00211	CcSEcCtD
Fomepizole—Bradycardia—Dexamethasone—psoriasis	0.000173	0.00211	CcSEcCtD
Fomepizole—Decreased appetite—Mycophenolic acid—psoriasis	0.00017	0.00208	CcSEcCtD
Fomepizole—Vertigo—Mycophenolate mofetil—psoriasis	0.00017	0.00208	CcSEcCtD
Fomepizole—Convulsion—Cyclosporine—psoriasis	0.000168	0.00206	CcSEcCtD
Fomepizole—Pain—Mycophenolic acid—psoriasis	0.000168	0.00205	CcSEcCtD
Fomepizole—Vision blurred—Prednisolone—psoriasis	0.000167	0.00203	CcSEcCtD
Fomepizole—Anxiety—Cyclosporine—psoriasis	0.000165	0.00201	CcSEcCtD
Fomepizole—Convulsion—Mycophenolate mofetil—psoriasis	0.000164	0.002	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—CXCL8—psoriasis	0.000164	0.00408	CbGpPWpGaD
Fomepizole—Visual impairment—Betamethasone—psoriasis	0.000163	0.00199	CcSEcCtD
Fomepizole—Visual impairment—Dexamethasone—psoriasis	0.000163	0.00199	CcSEcCtD
Fomepizole—Anxiety—Mycophenolate mofetil—psoriasis	0.000161	0.00196	CcSEcCtD
Fomepizole—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.00016	0.00196	CcSEcCtD
Fomepizole—Diarrhoea—Hydroxyurea—psoriasis	0.00016	0.00195	CcSEcCtD
Fomepizole—Dysgeusia—Triamcinolone—psoriasis	0.000159	0.00194	CcSEcCtD
Fomepizole—Vertigo—Prednisolone—psoriasis	0.000159	0.00194	CcSEcCtD
Fomepizole—Back pain—Triamcinolone—psoriasis	0.000157	0.00192	CcSEcCtD
Fomepizole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000156	0.00389	CbGpPWpGaD
Fomepizole—Vertigo—Hydrocortisone—psoriasis	0.000155	0.00189	CcSEcCtD
Fomepizole—Abdominal pain—Mycophenolic acid—psoriasis	0.000155	0.00189	CcSEcCtD
Fomepizole—Body temperature increased—Mycophenolic acid—psoriasis	0.000155	0.00189	CcSEcCtD
Fomepizole—Dizziness—Hydroxyurea—psoriasis	0.000155	0.00189	CcSEcCtD
Fomepizole—Convulsion—Prednisolone—psoriasis	0.000153	0.00187	CcSEcCtD
Fomepizole—Eosinophilia—Methotrexate—psoriasis	0.000153	0.00186	CcSEcCtD
Fomepizole—Shock—Mycophenolate mofetil—psoriasis	0.000152	0.00186	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—JUN—psoriasis	0.000152	0.00379	CbGpPWpGaD
Fomepizole—Tachycardia—Mycophenolate mofetil—psoriasis	0.000151	0.00184	CcSEcCtD
Fomepizole—Bradycardia—Prednisone—psoriasis	0.00015	0.00183	CcSEcCtD
Fomepizole—Convulsion—Hydrocortisone—psoriasis	0.00015	0.00183	CcSEcCtD
Fomepizole—Vomiting—Hydroxyurea—psoriasis	0.000149	0.00182	CcSEcCtD
Fomepizole—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000148	0.00368	CbGpPWpGaD
Fomepizole—Rash—Hydroxyurea—psoriasis	0.000148	0.0018	CcSEcCtD
Fomepizole—Dermatitis—Hydroxyurea—psoriasis	0.000147	0.0018	CcSEcCtD
Fomepizole—Headache—Hydroxyurea—psoriasis	0.000147	0.00179	CcSEcCtD
Fomepizole—Anxiety—Hydrocortisone—psoriasis	0.000147	0.00179	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—NFKB1—psoriasis	0.000146	0.00365	CbGpPWpGaD
Fomepizole—Vertigo—Triamcinolone—psoriasis	0.000146	0.00178	CcSEcCtD
Fomepizole—Hypotension—Mycophenolate mofetil—psoriasis	0.000145	0.00176	CcSEcCtD
Fomepizole—Shock—Prednisolone—psoriasis	0.000142	0.00173	CcSEcCtD
Fomepizole—Somnolence—Cyclosporine—psoriasis	0.000141	0.00172	CcSEcCtD
Fomepizole—Convulsion—Triamcinolone—psoriasis	0.000141	0.00172	CcSEcCtD
Fomepizole—Tachycardia—Prednisolone—psoriasis	0.000141	0.00172	CcSEcCtD
Fomepizole—Dyspepsia—Cyclosporine—psoriasis	0.00014	0.0017	CcSEcCtD
Fomepizole—Nausea—Hydroxyurea—psoriasis	0.000139	0.0017	CcSEcCtD
Fomepizole—Shock—Hydrocortisone—psoriasis	0.000139	0.00169	CcSEcCtD
Fomepizole—Decreased appetite—Cyclosporine—psoriasis	0.000138	0.00168	CcSEcCtD
Fomepizole—ADH1B—Metabolism—CARM1—psoriasis	0.000138	0.00344	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CARM1—psoriasis	0.000138	0.00344	CbGpPWpGaD
Fomepizole—Tachycardia—Hydrocortisone—psoriasis	0.000138	0.00168	CcSEcCtD
Fomepizole—Somnolence—Mycophenolate mofetil—psoriasis	0.000138	0.00168	CcSEcCtD
Fomepizole—Drowsiness—Methotrexate—psoriasis	0.000137	0.00168	CcSEcCtD
Fomepizole—Flushing—Prednisone—psoriasis	0.000137	0.00167	CcSEcCtD
Fomepizole—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000136	0.00166	CcSEcCtD
Fomepizole—Pain—Cyclosporine—psoriasis	0.000136	0.00166	CcSEcCtD
Fomepizole—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000135	0.00164	CcSEcCtD
Fomepizole—Diarrhoea—Mycophenolic acid—psoriasis	0.000134	0.00164	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—VEGFA—psoriasis	0.000133	0.00331	CbGpPWpGaD
Fomepizole—Vertigo—Dexamethasone—psoriasis	0.000133	0.00162	CcSEcCtD
Fomepizole—Vertigo—Betamethasone—psoriasis	0.000133	0.00162	CcSEcCtD
Fomepizole—Pain—Mycophenolate mofetil—psoriasis	0.000132	0.00161	CcSEcCtD
Fomepizole—Hypotension—Hydrocortisone—psoriasis	0.000132	0.00161	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—STAT3—psoriasis	0.000132	0.00328	CbGpPWpGaD
Fomepizole—Shock—Triamcinolone—psoriasis	0.000131	0.00159	CcSEcCtD
Fomepizole—Gastrointestinal pain—Cyclosporine—psoriasis	0.00013	0.00158	CcSEcCtD
Fomepizole—Dizziness—Mycophenolic acid—psoriasis	0.00013	0.00158	CcSEcCtD
Fomepizole—Tachycardia—Triamcinolone—psoriasis	0.00013	0.00158	CcSEcCtD
Fomepizole—Convulsion—Betamethasone—psoriasis	0.000128	0.00156	CcSEcCtD
Fomepizole—Convulsion—Dexamethasone—psoriasis	0.000128	0.00156	CcSEcCtD
Fomepizole—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000127	0.00154	CcSEcCtD
Fomepizole—Body temperature increased—Cyclosporine—psoriasis	0.000125	0.00153	CcSEcCtD
Fomepizole—Abdominal pain—Cyclosporine—psoriasis	0.000125	0.00153	CcSEcCtD
Fomepizole—Anxiety—Dexamethasone—psoriasis	0.000125	0.00153	CcSEcCtD
Fomepizole—Anxiety—Betamethasone—psoriasis	0.000125	0.00153	CcSEcCtD
Fomepizole—Vomiting—Mycophenolic acid—psoriasis	0.000125	0.00152	CcSEcCtD
Fomepizole—CAT—Metabolism—CARM1—psoriasis	0.000124	0.00309	CbGpPWpGaD
Fomepizole—Dyspepsia—Hydrocortisone—psoriasis	0.000124	0.00151	CcSEcCtD
Fomepizole—Rash—Mycophenolic acid—psoriasis	0.000124	0.00151	CcSEcCtD
Fomepizole—Dermatitis—Mycophenolic acid—psoriasis	0.000124	0.00151	CcSEcCtD
Fomepizole—Pain—Prednisolone—psoriasis	0.000123	0.00151	CcSEcCtD
Fomepizole—Headache—Mycophenolic acid—psoriasis	0.000123	0.0015	CcSEcCtD
Fomepizole—Decreased appetite—Hydrocortisone—psoriasis	0.000123	0.0015	CcSEcCtD
Fomepizole—Pharyngitis—Methotrexate—psoriasis	0.000122	0.00149	CcSEcCtD
Fomepizole—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000122	0.00149	CcSEcCtD
Fomepizole—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000122	0.00149	CcSEcCtD
Fomepizole—Vision blurred—Prednisone—psoriasis	0.000121	0.00148	CcSEcCtD
Fomepizole—Pain—Hydrocortisone—psoriasis	0.000121	0.00147	CcSEcCtD
Fomepizole—Visual impairment—Methotrexate—psoriasis	0.000119	0.00145	CcSEcCtD
Fomepizole—Anaemia—Prednisone—psoriasis	0.000119	0.00145	CcSEcCtD
Fomepizole—Shock—Dexamethasone—psoriasis	0.000118	0.00145	CcSEcCtD
Fomepizole—Shock—Betamethasone—psoriasis	0.000118	0.00145	CcSEcCtD
Fomepizole—Agitation—Prednisone—psoriasis	0.000118	0.00144	CcSEcCtD
Fomepizole—Tachycardia—Dexamethasone—psoriasis	0.000118	0.00143	CcSEcCtD
Fomepizole—Tachycardia—Betamethasone—psoriasis	0.000118	0.00143	CcSEcCtD
Fomepizole—Dyspepsia—Triamcinolone—psoriasis	0.000117	0.00143	CcSEcCtD
Fomepizole—Nausea—Mycophenolic acid—psoriasis	0.000116	0.00142	CcSEcCtD
Fomepizole—Vertigo—Prednisone—psoriasis	0.000115	0.00141	CcSEcCtD
Fomepizole—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000115	0.00141	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CARM1—psoriasis	0.000114	0.00285	CbGpPWpGaD
Fomepizole—Pain—Triamcinolone—psoriasis	0.000114	0.00139	CcSEcCtD
Fomepizole—Hypotension—Dexamethasone—psoriasis	0.000113	0.00137	CcSEcCtD
Fomepizole—Hypotension—Betamethasone—psoriasis	0.000113	0.00137	CcSEcCtD
Fomepizole—Body temperature increased—Hydrocortisone—psoriasis	0.000111	0.00136	CcSEcCtD
Fomepizole—Abdominal pain—Hydrocortisone—psoriasis	0.000111	0.00136	CcSEcCtD
Fomepizole—Convulsion—Prednisone—psoriasis	0.000111	0.00136	CcSEcCtD
Fomepizole—CYP2E1—tendon—psoriasis	0.000111	0.0276	CbGeAlD
Fomepizole—Anxiety—Prednisone—psoriasis	0.000109	0.00133	CcSEcCtD
Fomepizole—Diarrhoea—Cyclosporine—psoriasis	0.000109	0.00132	CcSEcCtD
Fomepizole—Dyspepsia—Betamethasone—psoriasis	0.000106	0.00129	CcSEcCtD
Fomepizole—Dyspepsia—Dexamethasone—psoriasis	0.000106	0.00129	CcSEcCtD
Fomepizole—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000106	0.00129	CcSEcCtD
Fomepizole—Dysgeusia—Methotrexate—psoriasis	0.000105	0.00128	CcSEcCtD
Fomepizole—Body temperature increased—Triamcinolone—psoriasis	0.000105	0.00128	CcSEcCtD
Fomepizole—Dizziness—Cyclosporine—psoriasis	0.000105	0.00128	CcSEcCtD
Fomepizole—Decreased appetite—Betamethasone—psoriasis	0.000105	0.00128	CcSEcCtD
Fomepizole—Decreased appetite—Dexamethasone—psoriasis	0.000105	0.00128	CcSEcCtD
Fomepizole—Back pain—Methotrexate—psoriasis	0.000104	0.00127	CcSEcCtD
Fomepizole—Shock—Prednisone—psoriasis	0.000103	0.00126	CcSEcCtD
Fomepizole—Pain—Dexamethasone—psoriasis	0.000103	0.00126	CcSEcCtD
Fomepizole—Pain—Betamethasone—psoriasis	0.000103	0.00126	CcSEcCtD
Fomepizole—Tachycardia—Prednisone—psoriasis	0.000102	0.00125	CcSEcCtD
Fomepizole—Dizziness—Mycophenolate mofetil—psoriasis	0.000102	0.00125	CcSEcCtD
Fomepizole—Vision blurred—Methotrexate—psoriasis	0.000101	0.00124	CcSEcCtD
Fomepizole—Vomiting—Cyclosporine—psoriasis	0.000101	0.00123	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—TP53—psoriasis	0.0001	0.0025	CbGpPWpGaD
Fomepizole—Rash—Cyclosporine—psoriasis	0.0001	0.00122	CcSEcCtD
Fomepizole—Dermatitis—Cyclosporine—psoriasis	9.99e-05	0.00122	CcSEcCtD
Fomepizole—Headache—Cyclosporine—psoriasis	9.94e-05	0.00121	CcSEcCtD
Fomepizole—Anaemia—Methotrexate—psoriasis	9.93e-05	0.00121	CcSEcCtD
Fomepizole—Gastrointestinal pain—Dexamethasone—psoriasis	9.85e-05	0.0012	CcSEcCtD
Fomepizole—Gastrointestinal pain—Betamethasone—psoriasis	9.85e-05	0.0012	CcSEcCtD
Fomepizole—Vomiting—Mycophenolate mofetil—psoriasis	9.84e-05	0.0012	CcSEcCtD
Fomepizole—Rash—Mycophenolate mofetil—psoriasis	9.76e-05	0.00119	CcSEcCtD
Fomepizole—Dermatitis—Mycophenolate mofetil—psoriasis	9.75e-05	0.00119	CcSEcCtD
Fomepizole—Headache—Mycophenolate mofetil—psoriasis	9.69e-05	0.00118	CcSEcCtD
Fomepizole—Vertigo—Methotrexate—psoriasis	9.65e-05	0.00118	CcSEcCtD
Fomepizole—Diarrhoea—Hydrocortisone—psoriasis	9.65e-05	0.00118	CcSEcCtD
Fomepizole—Dizziness—Prednisolone—psoriasis	9.55e-05	0.00116	CcSEcCtD
Fomepizole—Body temperature increased—Betamethasone—psoriasis	9.52e-05	0.00116	CcSEcCtD
Fomepizole—Body temperature increased—Dexamethasone—psoriasis	9.52e-05	0.00116	CcSEcCtD
Fomepizole—Abdominal pain—Betamethasone—psoriasis	9.52e-05	0.00116	CcSEcCtD
Fomepizole—Abdominal pain—Dexamethasone—psoriasis	9.52e-05	0.00116	CcSEcCtD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	9.46e-05	0.00236	CbGpPWpGaD
Fomepizole—Nausea—Cyclosporine—psoriasis	9.42e-05	0.00115	CcSEcCtD
Fomepizole—Dizziness—Hydrocortisone—psoriasis	9.32e-05	0.00114	CcSEcCtD
Fomepizole—Convulsion—Methotrexate—psoriasis	9.31e-05	0.00114	CcSEcCtD
Fomepizole—Dyspepsia—Prednisone—psoriasis	9.23e-05	0.00113	CcSEcCtD
Fomepizole—Nausea—Mycophenolate mofetil—psoriasis	9.19e-05	0.00112	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—IL6—psoriasis	9.19e-05	0.00229	CbGpPWpGaD
Fomepizole—Decreased appetite—Prednisone—psoriasis	9.12e-05	0.00111	CcSEcCtD
Fomepizole—Rash—Prednisolone—psoriasis	9.1e-05	0.00111	CcSEcCtD
Fomepizole—Dermatitis—Prednisolone—psoriasis	9.09e-05	0.00111	CcSEcCtD
Fomepizole—Headache—Prednisolone—psoriasis	9.04e-05	0.0011	CcSEcCtD
Fomepizole—Vomiting—Hydrocortisone—psoriasis	8.96e-05	0.00109	CcSEcCtD
Fomepizole—Rash—Hydrocortisone—psoriasis	8.89e-05	0.00108	CcSEcCtD
Fomepizole—Dermatitis—Hydrocortisone—psoriasis	8.88e-05	0.00108	CcSEcCtD
Fomepizole—Headache—Hydrocortisone—psoriasis	8.83e-05	0.00108	CcSEcCtD
Fomepizole—Dizziness—Triamcinolone—psoriasis	8.78e-05	0.00107	CcSEcCtD
Fomepizole—Gastrointestinal pain—Prednisone—psoriasis	8.58e-05	0.00105	CcSEcCtD
Fomepizole—Nausea—Prednisolone—psoriasis	8.57e-05	0.00105	CcSEcCtD
Fomepizole—ADH1C—Metabolism—CAT—psoriasis	8.48e-05	0.00211	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CAT—psoriasis	8.48e-05	0.00211	CbGpPWpGaD
Fomepizole—Vomiting—Triamcinolone—psoriasis	8.44e-05	0.00103	CcSEcCtD
Fomepizole—Nausea—Hydrocortisone—psoriasis	8.37e-05	0.00102	CcSEcCtD
Fomepizole—Rash—Triamcinolone—psoriasis	8.37e-05	0.00102	CcSEcCtD
Fomepizole—Dermatitis—Triamcinolone—psoriasis	8.36e-05	0.00102	CcSEcCtD
Fomepizole—Headache—Triamcinolone—psoriasis	8.32e-05	0.00101	CcSEcCtD
Fomepizole—Abdominal pain—Prednisone—psoriasis	8.29e-05	0.00101	CcSEcCtD
Fomepizole—Body temperature increased—Prednisone—psoriasis	8.29e-05	0.00101	CcSEcCtD
Fomepizole—Diarrhoea—Betamethasone—psoriasis	8.24e-05	0.00101	CcSEcCtD
Fomepizole—Diarrhoea—Dexamethasone—psoriasis	8.24e-05	0.00101	CcSEcCtD
Fomepizole—Hypotension—Methotrexate—psoriasis	8.19e-05	0.001	CcSEcCtD
Fomepizole—Dizziness—Betamethasone—psoriasis	7.96e-05	0.000972	CcSEcCtD
Fomepizole—Dizziness—Dexamethasone—psoriasis	7.96e-05	0.000972	CcSEcCtD
Fomepizole—Nausea—Triamcinolone—psoriasis	7.88e-05	0.000962	CcSEcCtD
Fomepizole—Somnolence—Methotrexate—psoriasis	7.79e-05	0.000951	CcSEcCtD
Fomepizole—Dyspepsia—Methotrexate—psoriasis	7.72e-05	0.000942	CcSEcCtD
Fomepizole—Vomiting—Dexamethasone—psoriasis	7.66e-05	0.000935	CcSEcCtD
Fomepizole—Vomiting—Betamethasone—psoriasis	7.66e-05	0.000935	CcSEcCtD
Fomepizole—Decreased appetite—Methotrexate—psoriasis	7.62e-05	0.00093	CcSEcCtD
Fomepizole—Rash—Dexamethasone—psoriasis	7.59e-05	0.000927	CcSEcCtD
Fomepizole—Rash—Betamethasone—psoriasis	7.59e-05	0.000927	CcSEcCtD
Fomepizole—Dermatitis—Dexamethasone—psoriasis	7.59e-05	0.000926	CcSEcCtD
Fomepizole—Dermatitis—Betamethasone—psoriasis	7.59e-05	0.000926	CcSEcCtD
Fomepizole—Headache—Betamethasone—psoriasis	7.55e-05	0.000921	CcSEcCtD
Fomepizole—Headache—Dexamethasone—psoriasis	7.55e-05	0.000921	CcSEcCtD
Fomepizole—Pain—Methotrexate—psoriasis	7.5e-05	0.000915	CcSEcCtD
Fomepizole—Diarrhoea—Prednisone—psoriasis	7.18e-05	0.000876	CcSEcCtD
Fomepizole—Gastrointestinal pain—Methotrexate—psoriasis	7.17e-05	0.000875	CcSEcCtD
Fomepizole—Nausea—Betamethasone—psoriasis	7.15e-05	0.000873	CcSEcCtD
Fomepizole—Nausea—Dexamethasone—psoriasis	7.15e-05	0.000873	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CAT—psoriasis	7.02e-05	0.00175	CbGpPWpGaD
Fomepizole—Dizziness—Prednisone—psoriasis	6.94e-05	0.000847	CcSEcCtD
Fomepizole—Abdominal pain—Methotrexate—psoriasis	6.93e-05	0.000846	CcSEcCtD
Fomepizole—Body temperature increased—Methotrexate—psoriasis	6.93e-05	0.000846	CcSEcCtD
Fomepizole—Vomiting—Prednisone—psoriasis	6.67e-05	0.000814	CcSEcCtD
Fomepizole—Rash—Prednisone—psoriasis	6.61e-05	0.000807	CcSEcCtD
Fomepizole—Dermatitis—Prednisone—psoriasis	6.61e-05	0.000806	CcSEcCtD
Fomepizole—ADH1C—Metabolism—APOE—psoriasis	6.59e-05	0.00164	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—APOE—psoriasis	6.59e-05	0.00164	CbGpPWpGaD
Fomepizole—Headache—Prednisone—psoriasis	6.57e-05	0.000802	CcSEcCtD
Fomepizole—Nausea—Prednisone—psoriasis	6.23e-05	0.00076	CcSEcCtD
Fomepizole—Diarrhoea—Methotrexate—psoriasis	6e-05	0.000732	CcSEcCtD
Fomepizole—CAT—Metabolism—APOE—psoriasis	5.93e-05	0.00148	CbGpPWpGaD
Fomepizole—Dizziness—Methotrexate—psoriasis	5.8e-05	0.000707	CcSEcCtD
Fomepizole—ADH1B—Metabolism—PPARG—psoriasis	5.74e-05	0.00143	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PPARG—psoriasis	5.74e-05	0.00143	CbGpPWpGaD
Fomepizole—Vomiting—Methotrexate—psoriasis	5.57e-05	0.00068	CcSEcCtD
Fomepizole—Rash—Methotrexate—psoriasis	5.53e-05	0.000675	CcSEcCtD
Fomepizole—Dermatitis—Methotrexate—psoriasis	5.52e-05	0.000674	CcSEcCtD
Fomepizole—Headache—Methotrexate—psoriasis	5.49e-05	0.00067	CcSEcCtD
Fomepizole—ADH1A—Metabolism—APOE—psoriasis	5.46e-05	0.00136	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—NDUFA5—psoriasis	5.33e-05	0.00133	CbGpPWpGaD
Fomepizole—Nausea—Methotrexate—psoriasis	5.21e-05	0.000635	CcSEcCtD
Fomepizole—CAT—Metabolism—PPARG—psoriasis	5.17e-05	0.00129	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PPARG—psoriasis	4.75e-05	0.00119	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CYP2S1—psoriasis	4.54e-05	0.00113	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—NDUFA5—psoriasis	4.22e-05	0.00105	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CYP2S1—psoriasis	3.58e-05	0.000893	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CARM1—psoriasis	2.21e-05	0.000552	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CARM1—psoriasis	1.75e-05	0.000436	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CAT—psoriasis	1.36e-05	0.00034	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CAT—psoriasis	1.08e-05	0.000268	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—APOE—psoriasis	1.06e-05	0.000264	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PPARG—psoriasis	9.22e-06	0.00023	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—APOE—psoriasis	8.37e-06	0.000209	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PPARG—psoriasis	7.29e-06	0.000182	CbGpPWpGaD
